Trial Profile
A study evaluating role of 68Ga-PSMA-PET imaging in staging and radiotherapy management in patients with biochemically recurrent prostate cancer.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2017
Price :
$35
*
At a glance
- Drugs Gallium (68Ga) gozetotide (Primary)
- Indications Prostate cancer
- Focus Diagnostic use
- 04 Sep 2017 New trial record